Trends in the Prevalence of Clinical and Preclinical Obesity Among US Adults by Social Determinants of Health
Obesity · 2026
DOI: 10.1002/oby.70147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2026. Verfasst von Xu-Fen Zeng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Obesity, Social Determinants of Health. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Wenzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Objective
This study examined trends in clinical and preclinical obesity prevalence among US adults and their association with social determinants of health (SDOH) from 1999 to 2023.
Methods
We analyzed data from 60,506 adults aged ≥ 20 years in 11 cycles of the National Health and Nutrition Examination Survey (1999–2023). Clinical obesity was defined per the Lancet Diabetes & Endocrinology Commission on the definition and diagnosis of clinical obesity and preclinical obesity by excess adiposity without obesity‐attributable complications. Eight SDOH domains were assessed individually and as a cumulative burden score. Age‐standardized prevalence and associations were estimated using survey‐weighted regression models.
Results
From 1999–2000 to 2021–2023, age‐standardized prevalence of clinical obesity nearly doubled (14.3% to 26.6%; p < 0.001), driven by increases in class III obesity. Preclinical obesity increased modestly (17.1% to 20.6%; p = 0.038). Disparities widened significantly between those with highest (> 6) vs. lowest (< 3) cumulative SDOH burdens. In multivariable‐adjusted analyses, unemployment (OR 1.50), food insecurity (OR 1.38), and high cumulative SDOH burden (OR 1.48) were strongly associated with clinical versus preclinical obesity, particularly class II–III severity.
Conclusions
Clinical obesity increased dramatically, showing a strong dose–response relationship with social disadvantage and widening SDOH‐based disparities, underscoring the need for targeted interventions addressing structural determinants among vulnerable populations. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Nutrition, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China.
- Department of Sports Science, Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Ming-Hua Zheng
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Wenzhou Municipal Science and Technology Bureau
Zitieren
APA
Zeng, X. F., Lian, L. Y., Cao, Y. Y., Miao, K. W., Li, F., Zhang, R., & Zheng, M. H. (2026). Trends in the Prevalence of Clinical and Preclinical Obesity Among US Adults by Social Determinants of Health. Obesity. https://doi.org/10.1002/oby.70147
Vancouver
Zeng XF, Lian LY, Cao YY, Miao KW, Li F, Zhang R, et al. Trends in the Prevalence of Clinical and Preclinical Obesity Among US Adults by Social Determinants of Health. Obesity. 2026. doi:10.1002/oby.70147
BibTeX
@article{Zeng2026,
author = {Zeng, Xu-Fen and Lian, Li-You and Cao, Ying-Ying and Miao, Kai-Wen and Li, Feng and Zhang, Rui and Zheng, Ming-Hua},
title = {Trends in the Prevalence of Clinical and Preclinical Obesity Among US Adults by Social Determinants of Health},
journal = {Obesity},
year = {2026},
doi = {10.1002/oby.70147}
}
EUVIMED